HomeBUSINESS
BUSINESS

Eisai’s 1st Half Operating Profit Zooms 74% on Lenvima Boon
(Nov.2.2018)

Eisai said on November 1 that its April-September sales grew 8.8% year on year thanks to solid revenues from global brands, with its operating profit spiking 74.4% as the company’s global partnership with US Merck on Lenvima (lenvatinib) gave a boost ...
(LOG IN FOR FULL STORY)